Literature DB >> 19653322

Chitooligosaccharides promote peripheral nerve regeneration in a rabbit common peroneal nerve crush injury model.

Yanpei Gong1, Leilei Gong, Xiaosong Gu, Fei Ding.   

Abstract

Chitooligosaccharides (COSs) are the biodegradation products of chitosan that have been demonstrated with neuroaffinity and/or neuroprotective actions. In this study, we investigated the possible benefits of treatment with COSs on nerve regeneration after crush injuries to peripheral nerves. The rabbits with the crushed common peroneal nerve were treated by daily intravenous injection of 1.5 or 3 mg/kg body weight of COSs or identical volume of saline (as the control) for a 6-week period. At the end of COSs treatment, electrophysiological assessments, Meyer's trichrome and Masson trichrome staining, and transmission electron microscopy were used to evaluate the regeneration of injured common peroneal nerve and atrophy of the tibialis posterior muscle. The results showed that the compound muscle action potentials, the number of regenerated myelinated nerve fibers, the thickness of regenerated myelin sheaths, and the cross-sectional area of tibialis posterior muscle fibers were significantly improved in the nerves that received COSs treatment and the results with COSs treatment displayed a dose-dependent pattern. This study demonstrated that COSs accelerated peripheral nerve regeneration after crush injury to rabbit common peroneal nerves. The COSs could probably become a potential neuroprotective agent for improvement of peripheral nerve regeneration after the injury and deserve for further studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653322     DOI: 10.1002/micr.20686

Source DB:  PubMed          Journal:  Microsurgery        ISSN: 0738-1085            Impact factor:   2.425


  13 in total

1.  Closing the Gap: Bridging Peripheral Sensory Nerve Defects with a Chitosan-Based Conduit a Randomized Prospective Clinical Trial.

Authors:  Arne Böcker; Martin Aman; Ulrich Kneser; Leila Harhaus; Frank Siemers; Felix Stang
Journal:  J Pers Med       Date:  2022-05-30

Review 2.  Chitin research revisited.

Authors:  Feisal Khoushab; Montarop Yamabhai
Journal:  Mar Drugs       Date:  2010-06-28       Impact factor: 5.118

3.  Seawater immersion aggravates sciatic nerve injury in rats.

Authors:  Haifeng Wang; Jian Fang; Feng Hu; Gewei Li; H E Hong
Journal:  Exp Ther Med       Date:  2015-02-09       Impact factor: 2.447

4.  Immunostimulative Activity of Low Molecular Weight Chitosans in RAW264.7 Macrophages.

Authors:  Ning Wu; Zheng-Shun Wen; Xing-Wei Xiang; Yan-Na Huang; Yang Gao; You-Le Qu
Journal:  Mar Drugs       Date:  2015-09-30       Impact factor: 5.118

Review 5.  An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.

Authors:  Cui Hao; Wei Wang; Shuyao Wang; Lijuan Zhang; Yunliang Guo
Journal:  Mar Drugs       Date:  2017-03-23       Impact factor: 5.118

6.  The neurochemistry of peripheral nerve regeneration.

Authors:  Andreea Benga; Fatih Zor; Ahmet Korkmaz; Bogdan Marinescu; Vijay Gorantla
Journal:  Indian J Plast Surg       Date:  2017 Jan-Apr

Review 7.  Chitooligosaccharide and its derivatives: preparation and biological applications.

Authors:  Gaurav Lodhi; Yon-Suk Kim; Jin-Woo Hwang; Se-Kwon Kim; You-Jin Jeon; Jae-Young Je; Chang-Bum Ahn; Sang-Ho Moon; Byong-Tae Jeon; Pyo-Jam Park
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

8.  Effect of Frankincense Extract on Nerve Recovery in the Rat Sciatic Nerve Damage Model.

Authors:  Xiaowen Jiang; Jun Ma; Qingwei Wei; Xinxin Feng; Lu Qiao; Lin Liu; Binqing Zhang; Wenhui Yu
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-10       Impact factor: 2.629

9.  Molecular Weight-Dependent Immunostimulative Activity of Low Molecular Weight Chitosan via Regulating NF-κB and AP-1 Signaling Pathways in RAW264.7 Macrophages.

Authors:  Bin Zheng; Zheng-Shun Wen; Yun-Juan Huang; Mei-Sheng Xia; Xing-Wei Xiang; You-Le Qu
Journal:  Mar Drugs       Date:  2016-09-20       Impact factor: 5.118

Review 10.  Application of Chitosan, Chitooligosaccharide, and Their Derivatives in the Treatment of Alzheimer's Disease.

Authors:  Qian-Qian Ouyang; Shannon Zhao; Si-Dong Li; Cai Song
Journal:  Mar Drugs       Date:  2017-11-07       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.